Package 25021-219-20

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 25021-219-20
Digits Only 2502121920
Product NDC 25021-219
Product ID 25021-219_350e175f-f66a-4707-a35a-c7460c3bd3d9
Description

1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2023-11-01
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Decitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "350e175f-f66a-4707-a35a-c7460c3bd3d9", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["749f8d8c-e378-42a1-b94a-136b606dadb4"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-219-20)  / 20 mL in 1 VIAL", "package_ndc": "25021-219-20", "marketing_start_date": "20231101"}], "brand_name": "Decitabine", "product_id": "25021-219_350e175f-f66a-4707-a35a-c7460c3bd3d9", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-219", "generic_name": "Decitabine", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA212826", "marketing_category": "ANDA", "marketing_start_date": "20231101", "listing_expiration_date": "20261231"}